comparemela.com
Home
Live Updates
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication : comparemela.com
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that it has expanded...
Related Keywords
Switzerland ,
Ukraine ,
United States ,
Israel ,
Russia ,
American ,
Russian ,
Sari Fishman ,
Fite Vp Business Development Dr ,
Fite Biopharma Ltd ,
Drug Administration ,
Can Fite Biopharma ,
Switzerland Based Ewopharma ,
Central Eastern European ,
Central Eastern Europe ,
Fite Biopharma ,
Orphan Drug Designation ,
Fast Track Designation ,
Annual Report ,
Markets ,
comparemela.com © 2020. All Rights Reserved.